Report libraryReview the Texas report and watch the video walkthrough to understand the findings and their limitations.
Data period: 2026-Q3
DOWNLOAD COMPLIMENTARY TEXAS REPORT ↓PDF report · No email address required · Watching the video below is optional
Start with the statewide comparisons, then examine the codes and regional peers relevant to your practice. These findings describe payer-published rates—not verified claim payments.
The independent-group E/M and well-visit composite is 83% of Medicare at Aetna, 92% at Cigna, and 94% at both BCBS of Texas and UnitedHealthcare. Across 848 independent groups with 99213 rates from at least two payers, the median spread between the highest and lowest published rate is 25% ($17.05).
System-employed groups’ median 99213 rates exceed independent medians by 6% at Aetna, 9% at BCBS of Texas, 20% at Cigna, and 29% at UnitedHealthcare. Regional variation can be as large as, or larger than, differences between payers. After counting one multi-market organization once, a consistent large-practice premium remains only at Cigna.
Independent-group median rates for vaccine administration code 90460 range from $10.00 at Aetna to $22.73 at Cigna. For HPV vaccine code 90651, BCBS of Texas publishes a median of $206.38 against the study’s $312.44 reference cost. The report flags that published rate for verification: check your own remittances and acquisition costs before treating it as your payment or margin.
Source: Executive summary and recommendations, pages 7–9; BCBS of Texas data notes, pages 10 and 69. Use the full report for code-level tables, peer counts, and context.
PMI used PayerIntel Texas extracts of Aetna, BCBS of Texas, Cigna, and UnitedHealthcare price-transparency files ingested in Q3 2026: 40 files, 3,883,767 rate rows, and 92 pediatric CPT codes. Reference inputs are the 2026 Medicare Physician Fee Schedule and a vaccine-cost reference dated September 22, 2026. No PMI client contracts, billing records, or claims enter the study.
The study includes 1,093 independent groups and 36 system-employed groups. Qualifying general pediatricians are identified by the report’s taxonomy rules; advanced practice providers do not enter peer medians. Independent groups must meet the general-pediatric share test; system groups are shown separately and require at least four pediatricians. Staffing, FQHC/safety-net, urgent-care, subspecialty/complex-care, out-of-state, and unresolved entities are excluded.
When a payer lists multiple rates for a pediatrician and code, the selection rule prioritizes fee-schedule rows, then office place of service, then the broadest plan bundle, then the upper-median of remaining rates. A group rate is the median of qualifying pediatricians’ representative rates; organization-only listings use the organization row. Statewide summaries use the median across groups, with 25th–75th percentiles and group counts.
Medicare comparisons use national 2026 non-facility amounts without geographic adjustment. The E/M and well-visit composite equally weights six codes: 99213, 99214, 99392, 99393, 99391, and 99381. The headline basket sums medians across ten codes without practice-volume weighting. Groups are assigned to the region containing the largest share of their pediatricians; multi-region groups remain in that region and are flagged.
Statistics based on fewer than three groups are suppressed; those based on three to seven are flagged as thin and should be treated as indicative. Solo duplicates are removed under the study’s rules; larger groups are not deduplicated.
A published rate is not necessarily the amount paid on a claim. Plan product, place of service, modifiers, and benefit design can affect actual payment. The study does not evaluate contract terms, collections, or a practice’s actual service volume. Its reference visit-mix illustrations are modeled comparisons, not measured practice revenue, forecasts, or guaranteed improvement.
Vaccine reference costs are base-tier member costs from a large buying group, net of discounts, rebate, and tax. Comparisons use the highest-cost brand when a code has multiple brands; your practice’s acquisition costs may differ. Statewide results are not a substitute for a practice-specific market comparison or verification against remittances.